SRTA
Strata Critical Medical, Inc.NASDAQIndustrials$4.15-0.72%ClosedMarket Cap: $361.0M
As of 2026-04-06
Valuation
P/E (TTM)
8.73
PEG
0.03
P/B
1.23
P/S
1.83
EV/EBITDA
-18.05
DCF Value
$-18.89
FCF Yield
-16.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
20.9%
Operating Margin
-11.3%
Net Margin
21.0%
ROE
16.5%
ROA
21.8%
ROIC
15.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $22.7M | -0.9% | $-4.2M | $-8.8M | $-0.11 | — |
| FY 2025 | $197.1M | 20.9% | $-22.4M | $41.3M | $0.50 | — |
| Q3 2025 | $49.3M | 23.6% | $-5.6M | $57.4M | $-0.04 | — |
| Q2 2025 | $70.8M | 25.1% | $-5.0M | $-3.7M | $-0.05 | — |
| Q1 2025 | $54.3M | 22.1% | $-7.6M | $-3.5M | $-0.04 | — |
| Q4 2024 | $54.4M | 23.2% | $-8.4M | $-9.8M | $-0.12 | — |
| FY 2024 | $248.7M | 23.7% | $-33.9M | $-27.3M | $-0.35 | — |
| Q3 2024 | $74.9M | 26.5% | $-3.5M | $-2.0M | $-0.03 | — |
| Q2 2024 | $67.9M | 24.1% | $-12.1M | $-11.3M | $-0.15 | — |
| Q1 2024 | $51.5M | 19.7% | $-9.9M | $-4.2M | $-0.06 | — |
| Q4 2023 | $47.5M | 19.0% | $-35.6M | $-33.9M | $-0.45 | — |
| FY 2023 | $225.2M | 18.7% | $-68.1M | $-56.1M | $-0.76 | — |